QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 27.52

-2.2%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike Relyea who wrote (371)	1/28/1997 10:07:00 PM
From: Robert Busse	of 1693

Mike, I saw the same thing on CNN about Gilead Sciences experimental influenza drug- It apparently hasn't been tried on humans yet, but it sounds like it has been more effective on animals than Glaxo's gg167 has been on humans - obviously, this is apples and oranges, tho- From our perspective, I'm not sure it makes much difference whether Glaxo or Gilead has the better drug to treat the flu- I'm not sure of the terms of QDEL's agreement w/ Glaxo re whether Glaxo is expected to promote or sell QDEL's test if their own drug is approved. Anyway, much like H. pylori, I think anything that heightens awareness of the availability of tests and drugs to diagnose and treat flu sufferers will inure to the benefit of all in the field-QDEL, Glaxo, and Gilead included. Also did you see where Biota (the actual developers of GG167 licensed to Glaxo) entered into agreement w/ a small private company (BioStar) for the development of an influenza diagnostic, apparently in competition w/ Qdel's tests- it said they expected it to be developed by late 1997-sounds a bit optimistic to me. BOB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next